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BioSentinel
The BioSentinel mission was selected in 
2013 as one of three secondary payloads 
to fly on the Space Launch System’s first 
Exploration Mission (EM-1) planned for 
launch in December 2017. The primary 
objective of BioSentinel is to demonstrate 
the use of simple model organisms as 
‘biosentinels’ to detect, measure, and 
correlate the impact of space radiation to 
biological organisms including humans, a 
health risk over long durations beyond Low 
Earth Orbit (LEO). While progress identifying 
and characterizing biological radiation 
effects using Earth-based facilities has been 
significant, no terrestrial source duplicates 
the unique space radiation environment.
The payload instrument, a biosensor called 
BioSentinel, uses the yeast S. cerevisiae 
to measure double strand breaks (DSBs) 
that occur in response to ambient space 
radiation. DSBs are deleterious DNA lesions 
that are generated by highly energetic 
particles in the deep-space radiation 
spectrum and that are often repaired without 
errors. Specifically engineered nutrient 
selection strategies ensure that only DSB 
and repaired cells will grow in the BioSentinel 
reporter strains of yeast. Therefore 
measurements taken of culture growth and 
metabolic activity will be used to directly 
indicate a successful DSB-and-repair event.
BioSentinel is a 6-Unit (6U) spacecraft 
measuring approximately 14.4 inches long, 
8.9 inches wide and 3.9 inches tall. It weighs 
about 30 pounds. At launch, BioSentinel 
resides within the second stage of the launch 
vehicle from which it is deployed to a lunar 
fly-by trajectory and into a heliocentric orbit 
where its distance to the sun is slightly closer 
than Earth’s, varying between 0.98 to 0.92 
AU. After completing the lunar fly-by and a 
two-week spacecraft check out, the science 
mission phase begins when the experiment 
start command is transmitted from the 
ground and initiates wetting of the first set of 
sample wells. Each set of wells is expected 
to be in its active biosentinel mode for 2 – 4 
weeks following hydration; multiple such 
sets are included in three microfluidic cards. 
The sample wells of each microfluidic card 
contain three yeast strains: BioSentinel, wild 
type (occurring in nature) and rad52 mutant, 
https://ntrs.nasa.gov/search.jsp?R=20190001646 2019-08-30T11:13:17+00:00Z
FS #2014-06-01-ARC 
National Aeronautics and Space Administration
Ames Research Center
Moffett Field, CA 94035
which are launched dry and are activated as described 
above by media addition at different time points over 
the 18-month mission. One reserve set of wells will be 
activated in the occurrence of a Solar Particle Event 
(SPE). Payload science data and spacecraft telemetry 
will be stored on board and then downloaded to the 
ground. This will continue over the duration of the 
mission. 
Growth will be measured using a 3-color LED detection 
system and the metabolic indicator dye Alamar 
Blue. Biological measurements will be compared 
to data provided by onboard physical sensors and 
dosimeters and to Earth-based experiments using 
relevant energetic particle types, energies, and doses. 
Additionally, three additional identical BioSentinel 
payloads will be developed – one for the ISS where 
there is similar microgravity but a LEO-radiation 
environment, one for use as a delayed-synchronous 
ground control at a 1g and a low radiation environment, 
and one ground payload that will be used at Brookhaven 
National Laboratory in New York. Thus the BioSentinel 
payload will help calibrate the biological effect of 
radiation in deep space to analogous measurements 
conducted on Earth and on the ISS.
BioSentinel will conduct the first study of biological 
response to space radiation outside LEO in over 40 
years. BioSentinel will address strategic knowledge 
gaps related to the biological effects of space radiation 
and will provide an adaptable platform to perform 
human-relevant measurements in multiple space 
environments. Yeast was selected for this mission as it 
is well-studied in space and its DNA repair mechanisms 
are common with human cells. BioSentinel’s results 
will be critical for improving interpretation of the effects 
of space radiation exposure, and for reducing the risk 
associated with long-term human exploration.
The BioSentinel mission is funded by the Advanced 
Exploration Systems program within the Human 
Exploration and Operations Missions Directorate at 
NASA Headquarters. Partner organizations include 
NASA Ames Research Center, NASA Johnson Space 
Center, Loma Linda University Medical Center, and 
University of Saskatchewan.
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